Entering text into the input field will update the search result below

Bio-Techne (TECH) Q4 2018 Results - Earnings Call Transcript

Aug. 07, 2018 5:26 PM ETBio-Techne Corporation (TECH)
SA Transcripts profile picture
SA Transcripts

Bio-Techne Corp. (NASDAQ:TECH) Q4 2018 Earnings Call August 7, 2018 9:00 AM ET


James T. Hippel - Bio-Techne Corp.

Charles R. Kummeth - Bio-Techne Corp.


Daniel Arias - Citigroup Global Markets, Inc.

Puneet Souda - Leerink Partners LLC

Catherine Ramsey Schulte - Robert W. Baird & Co.

Dan Leonard - Deutsche Bank Securities, Inc.

Amanda L. Murphy - William Blair & Co. LLC

Matthew G. Hewitt - Craig-Hallum Capital Group LLC


Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2018. At this time, all participants have been placed in listen-only mode and the call will be opened for questions following management's prepared remarks. Today's call is being recorded.

I would now like to turn the call over to Mr. Jim Hippel, Bio-Techne's Chief Financial Officer. Please go ahead, sir.

James T. Hippel - Bio-Techne Corp.

Good morning, and thank you for joining us. On the call with me this morning is Chuck Kummeth, Chief Executive Officer of Bio-Techne.

Before we begin, let me briefly cover our Safe Harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results. The company's 10-K for fiscal year 2017 identifies certain factors that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call.

The company does not undertake to update any forward-looking statements as a result of any new information or future events or developments. The 10-K as well as the company's other SEC filings are available on the company's website within its Investor Relations section.

During the call, non-GAAP financial measures may be used to provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.